Structural basis for airflow limitation in chronic obstructive pulmonary disease

Sarcoidosis Vasculitis and Diffuse Lung Diseases

Volumn 17, Issue 3, 2000, Pages 239-245

  Saetta, M ^a   Turato, G ^a   Zuin, R ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Airway inflammation; Emphysema; Smoking

Indexed keywords

AIRWAY OBSTRUCTION; AIRWAY RESISTANCE; CELL DESTRUCTION; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; ELASTICITY; EMPHYSEMA; HUMAN; INFLAMMATION; LUNG PARENCHYMA; LUNG STRUCTURE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RESPIRATORY AIRFLOW; REVIEW;

AIRWAY RESISTANCE; FEMALE; HUMAN; LUNG DISEASES, OBSTRUCTIVE; MALE; PROGNOSIS; PULMONARY EMPHYSEMA; PULMONARY GAS EXCHANGE; SEVERITY OF ILLNESS INDEX; SMOKING;

EID: 0033774940     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (66)

1. American thoracic Society: Standards for diagnosis and care of patients with chronic obstructive pulmonary disease
2. Tumor necrosis factor gone complex in COPD and disseminated bronchiectasis
3. Tumor necrosis factor-a gene promoter polymorphism in chronic obstructive pulmonary disease
4. Morphological and cellular basis for airflow limitation in smokers
5. The relevance in adults of airflow obstruction, but not of mucous hypersecretion, to mortality from chronic lung disease
6. 1 decline and chronic obstructive pulmonary disease morbidity
7. Site and nature of airway obstruction in chronic obstructive lung disease
8. Pathologic changes in the peripheral airways of young cigarette smokers
9. The relations between structural changes in small airways and pulmonary function tests
10. Loss of alveolar attachments in smokers: An early morphometric correlate of lung function impairment
11. Characterization of the inflammatory reaction in the peripheral airways of cigarette smoking using immunocytokemistry
12. CD8+ T-lymphocytes in the peripheral airways of smokers with chronic obstructive pulmonary disease
13. Goblet cell hyperplasia and epithelial inflammation in peripheral airways of smokers with both symptomds of chronic bronchitis and airflow limitation
14. Inflammatory cell distribution within and along asthmatic airways
15. Role of mast cell and neutrophil proteases in airway secretion
16. Inflammatory cells in the bronchial glands of smokers with chronic bronchitis
17. Cronic obstructive pulmonary disease: Role of bronchiolar mast cells and macrophages
18. Transforming growth factor betel and recruitment of macrophages and mast cells in airways in chronic obstructive pulmonary disease
19. Mast cells in the airway lumen and bronchial mucosa of patients with chronic bronchitis
20. Measurement of the bronchial mucous gland layer: A diagnostic yardstick in chronic bronchitis
21. Reassessment of inflammation of airways in chronic bronchitis
22. The National Institutes of Health intermittent positive-pressure breathing trial: Pathology studies. II. Correlation between morphologic findings, clinical findings, and evidence of expiratory airflow obstruction
23. Characteristics of the inflammation in biopsies from large airways of subjects with asthma and subjects with chronic airflow limitation
24. Activated T-lymphocytes and macrophages in bronchial mucosa of subjects with chronic bronchitis
25. Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary disease
26. Airway eosinophilia in chronic bronchitis during exacerbations
27. Airway eosinophilia and expression of IL-5 in asthma and in exacerbations of chronic bronchitis
28. Airflow limitation in chronic bronchitis is associated with T-lymphocyte and macrophage infiltration in the bronchial mucosa
29. Inflammation in bronchial biopsies of subjects with chronic bronchitis: Inverse relationship of CD8+ T lymphocytes with FEVI
30. CD8+ T cell subsets and chronic obstructive pulmonary disease
31. Glucocorticoid therapy for chronic obstructive pulmonary disease
32. Upregulation of adhesion molecules in the bronchial mucosa of subjects with chronic obstructive bronchitis
33. HLA-DR and ICAM-L expression on bronchial epithelial cells in asthma and chronic bronchitis
34. Rhinovirus infection induces expression of its own Receptor intercellular Adhesion Molecule I (ICAM-L) via increased NF-kB-mediated trascription
35. Lymphocyte dinamics in the pulmonary microenvironment: Implications for the pathophisiology of pulmonary sarcoidosis
36. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma
37. Intraluminal airway inflammation in chronic bronchitis. Characterization and correlation with clinical parameters
38. The effects of chronic bronchitis and chronic air-flow obstruction on lung cell populations recovered by bronchoalveolar lavage
39. Airway inflammation in smokers with nonobstructive and obstructive chronic bronchitis
40. Severity of airflow limitation is associated with severity of airway inflammation in smokers
41. Broncoscopic evaluation of severe asthma: Persistent inflammation associated with high dose glucocorticoids
42. Chemotactic cytokines: From the molecular level to clinical use
43. Chemokines: Chemotactic cytokines that mediate inflammation
44. Monocyte chemoattractant protein 1, interleukin 8, and chronic airway inflammation in COPD
45. Increased MCP-1 and MIP-1b in broncoalveolar lavage fluid of chronic bronchitis
46. Inflammatory cells and mediators in bronchial lavage of patients with chronic obstructive pulmonary disease
47. Airway inflammation in COPD assessed by sputum levels of interleukin -8
48. Interleukin-8 in airway inflammation in patients with asthma and chronic obstructive pulmonary disease
49. Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease
50. Airway neutrophils and interleukin-17
51. Comparison of induced sputum with bronchial wash. Bronchoalveolar lavage and bronchial biopsies in COPD
52. Collagen content of alveolar wall tissue in emphysematous and non-emphysematous lungs
53. Cellular and connective tissue changes in alveolar septal walls in emphysema
54. Destructive Index: A measurement of lung parenchymal destruction in smokers
55. Cellularity of the alveolar walls in smokers and its relation to alveolar destruction. Functional implications
56. CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease
57. Centrilobular and panlobular emphysema in smokers. Two distinct morphologic and functional entities
58. Pulmonary emphysema and alpha 1-antitrypsin deficiency
59. Morphometry of small airways in smokers and its relationship to emphysema type and hyperresponsiveness
60. Extent of centrilobular and panacinar emphysema in smokers lungs: Pathological and mechanical implications
61. Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis
62. Corticosteroid reversibility in COPD is related to features of asthma
63. The host factor in bronchitis
64. Bronchial hyperreactivity in smokers
65. Long-term treatment with inhaled budesonide in patients with mild chronic obstructive pulmonary disease who continue smoking
66. EUROSCOP, ISOLDE and the Copenhagen City Lung Study